Abstract 18172: A Pragmatic Evaluation of Familial Hypercholesterolemia Management: Gaps in Screening, Genetic Testing, and Lipid Optimization
Background: Familial hypercholesterolemia (FH) is a common inherited dyslipidemia affecting ~ 0.5% of adults worldwide and increases atherosclerotic cardiovascular disease (ASCVD) risk if untreated. Despite established clinical guidelines, FH remains underdiagnosed, with only 10% of cases captured in routine clinica...